271 related articles for article (PubMed ID: 26097546)
21. Impaired CCR9/CCL25 signalling induced by inefficient dendritic cells contributes to intestinal immune imbalance in nonalcoholic steatohepatitis.
Gao W; Wang Y; Bi J; Chen X; Li N; Wang Y; Tang H; Mao J
Biochem Biophys Res Commun; 2021 Jan; 534():34-40. PubMed ID: 33310185
[TBL] [Abstract][Full Text] [Related]
22. S100A8 Production in CXCR2-Expressing CD11b+Gr-1high Cells Aggravates Hepatitis in Mice Fed a High-Fat and High-Cholesterol Diet.
Mukai K; Miyagi T; Nishio K; Yokoyama Y; Yoshioka T; Saito Y; Tanaka S; Shigekawa M; Nawa T; Hikita H; Sakamori R; Yoshihara H; Imai Y; Hiramatsu N; Tatsumi T; Takehara T
J Immunol; 2016 Jan; 196(1):395-406. PubMed ID: 26608915
[TBL] [Abstract][Full Text] [Related]
23. Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.
Enos RT; Velázquez KT; McClellan JL; Cranford TL; Walla MD; Murphy EA
Nutr Res; 2015 May; 35(5):449-59. PubMed ID: 25934114
[TBL] [Abstract][Full Text] [Related]
24. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
25. DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model.
Achiwa K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Hirooka Y; Katano Y; Goto H
Biochem Biophys Res Commun; 2016 Jan; 470(1):15-21. PubMed ID: 26682925
[TBL] [Abstract][Full Text] [Related]
26. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis.
Liu X; Sun R; Li Z; Xiao R; Lv P; Sun X; Olson MA; Gong Y
Arch Biochem Biophys; 2021 Oct; 711():109019. PubMed ID: 34478730
[TBL] [Abstract][Full Text] [Related]
27. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation.
Shen T; Chen X; Li Y; Tang X; Jiang X; Yu C; Zheng Y; Guo H; Ling W
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1510-1518. PubMed ID: 28153707
[TBL] [Abstract][Full Text] [Related]
29. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
30. Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells.
Zhang F; Jiang WW; Li X; Qiu XY; Wu Z; Chi YJ; Cong X; Liu YL
J Dig Dis; 2016 Jul; 17(7):464-74. PubMed ID: 27216040
[TBL] [Abstract][Full Text] [Related]
31. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
Elshazly SM
Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
[TBL] [Abstract][Full Text] [Related]
32. Intestinal Trefoil Factor 3 Alleviates the Intestinal Barrier Function Through Reducing the Expression of TLR4 in Rats with Nonalcoholic Steatohepatitis.
Wang Y; Liang K; Kong W
Arch Med Res; 2019 Jan; 50(1):2-9. PubMed ID: 31101239
[TBL] [Abstract][Full Text] [Related]
33. [Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease].
Liu YT; Li YQ; Wang YZ
Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):921-926. PubMed ID: 28073414
[No Abstract] [Full Text] [Related]
34. Effects of polyphenol compounds melanin on NAFLD/NASH prevention.
Belemets N; Kobyliak N; Virchenko O; Falalyeyeva T; Olena T; Bodnar P; Savchuk O; Galenova T; Caprnda M; Rodrigo L; Skladany L; Delev D; Opatrilova R; Kruzliak P; Beregova T; Ostapchenko L
Biomed Pharmacother; 2017 Apr; 88():267-276. PubMed ID: 28110193
[TBL] [Abstract][Full Text] [Related]
35. Effect of folate supplementation on immunological and autophagy markers in experimental nonalcoholic fatty liver disease.
Youssry S; Kamel MA
Eur Cytokine Netw; 2019 Dec; 30(4):135-143. PubMed ID: 32096475
[TBL] [Abstract][Full Text] [Related]
36. Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier.
Lai X; Zhou H; Wan Y; Kuang J; Yang Y; Mai L; Chen Y; Liu B
Int Immunopharmacol; 2024 Feb; 128():111429. PubMed ID: 38171057
[TBL] [Abstract][Full Text] [Related]
37. Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation.
Zhou D; Pan Q; Liu XL; Yang RX; Chen YW; Liu C; Fan JG
J Gastroenterol Hepatol; 2017 Sep; 32(9):1640-1648. PubMed ID: 28109017
[TBL] [Abstract][Full Text] [Related]
38. Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity.
Hartmann P; Seebauer CT; Mazagova M; Horvath A; Wang L; Llorente C; Varki NM; Brandl K; Ho SB; Schnabl B
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(5):G310-22. PubMed ID: 26702135
[TBL] [Abstract][Full Text] [Related]
39. Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice.
Wu Z; Xu J; Tan J; Song Y; Liu L; Zhang F; Zhang Y; Li X; Chi Y; Liu Y
J Cell Mol Med; 2019 May; 23(5):3375-3385. PubMed ID: 30772951
[TBL] [Abstract][Full Text] [Related]
40. Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.
Khoury T; Ben Ya'acov A; Shabat Y; Zolotarovya L; Snir R; Ilan Y
World J Gastroenterol; 2015 Jun; 21(24):7443-56. PubMed ID: 26139990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
